Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
Cancer Chemotherapy and Pharmacology|January 1, 1992
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cellsV Gandhi, W PlunkettDrugs|January 1, 1994
Evolution of the arabinosides and the pharmacology of fludarabineW Plunkett, V GandhiCancer Research|June 15, 1990
Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosidesV Gandhi, W PlunkettHematology and Cell Therapy|December 1, 1996
Pharmacology of purine nucleoside analoguesW Plunkett, V GandhiBiochemical Pharmacology|October 15, 1989
Interaction of arabinosyl nucleotides in K562 human leukemia cellsV Gandhi, W PlunkettCancer Research|January 15, 1988
Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cellsV Gandhi, W PlunkettLeukemia & Lymphoma|January 1, 1994
Fludarabine inhibits DNA replication: a rationale for its use in the treatment of acute leukemiasV Gandhi, P Huang, W PlunkettSeminars in Oncology|October 1, 1990
Metabolism and action of fludarabine phosphateW Plunkett, P Huang, V GandhiAnti-Cancer Drugs|December 1, 1995
Preclinical characteristics of gemcitabineW Plunkett, P Huang, V GandhiCancer Chemotherapy and Pharmacology|January 1, 1996
The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cellsS Loughlin, V Gandhi, W Plunkett, et al.Pageof 32